肥厚型梗阻性心肌病的起搏治疗是否有效？
Pacing for hypertrophic obstructive cardiomyopathy does it work?
作者信息
Zaidi Q, Zaky H, Aljassim O
机构信息
Cardiology and Cardiothoracic Surgery Center, Dubai Hospital, P.O. Box 21910, Dubai, United Arab Emirates.
出版信息
J Saudi Heart Assoc. 2009 Jul;21(3):165-7. doi: 10.1016/j.jsha.2009.06.006. Epub 2009 Aug 5.
Abstract
Sixty-nine years old lady presented with sudden cardiac arrest, she was found to have hypertrophic obstructive cardiomyopathy, she refused septal myomectomy and had a dual chamber ICD implanted, she was put on right ventricular apical pacing with short AV interval, after pacing her max pressure gradient across left ventricular out flow tract (LVOT) dropped from 117 mmHg to 21 mmHg and her symptoms much improved over a follow up period of 1 year.
摘要
一位69岁女性因心脏骤停入院，被诊断为肥厚型梗阻性心肌病，她拒绝接受室间隔心肌切除术，植入了双腔植入式心脏复律除颤器（ICD），采用短房室间期的右心室心尖部起搏。起搏后，她左心室流出道（LVOT）的最大压力阶差从117 mmHg降至21 mmHg，症状在1年的随访期内有显著改善。
相似文献
1
Pacing for hypertrophic obstructive cardiomyopathy does it work?肥厚型梗阻性心肌病的起搏治疗是否有效？
J Saudi Heart Assoc. 2009 Jul;21(3):165-7. doi: 10.1016/j.jsha.2009.06.006. Epub 2009 Aug 5.
2
Successful treatment with biventricular pacing in a patient with hypertrophic obstructive cardiomyopathy.肥厚型梗阻性心肌病患者应用双心室起搏治疗成功。
Chin Med J (Engl). 2011 Apr;124(7):1105-8.
3
Treating a Structural Heart Disease Using a Non-structural Approach: Role of Cardiac Pacing in Hypertrophic Cardiomyopathy.采用非结构性方法治疗结构性心脏病：心脏起搏在肥厚型心肌病中的作用
Cardiol Res. 2017 Feb;8(1):20-25. doi: 10.14740/cr512w. Epub 2017 Mar 3.
4
Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.双腔（DDD）起搏治疗梗阻性肥厚型心肌病的长期结果。症状和血流动力学进行性改善及左心室肥厚减轻的证据。
Circulation. 1994 Dec;90(6):2731-42. doi: 10.1161/01.cir.90.6.2731.
5
Very late effects of dual chamber pacing therapy for obstructive hypertrophic cardiomyopathy.双腔起搏治疗梗阻性肥厚型心肌病的迟发效应。
Arch Cardiovasc Dis. 2013 Jun-Jul;106(6-7):373-81. doi: 10.1016/j.acvd.2013.04.003. Epub 2013 Jun 24.
6
Is surgery the gold standard in the treatment of obstructive hypertrophic cardiomyopathy?手术是梗阻性肥厚型心肌病治疗的金标准吗？
Interact Cardiovasc Thorac Surg. 2013 Jan;16(1):5-9. doi: 10.1093/icvts/ivs352. Epub 2012 Sep 30.
7
The importance of ventricular septal morphology in the effectiveness of dual chamber pacing in hypertrophic obstructive cardiomyopathy.室间隔形态对肥厚型梗阻性心肌病双腔起搏疗效的重要性。
Pacing Clin Electrophysiol. 2000 Sep;23(9):1324-9. doi: 10.1111/j.1540-8159.2000.tb00958.x.
8
Long-term effects of dual-chamber pacing with periodic echocardiographic evaluation of optimal atrioventricular delay in patients with hypertrophic cardiomyopathy >50 years of age.对年龄大于50岁的肥厚型心肌病患者进行双腔起搏并定期进行超声心动图评估最佳房室延迟的长期影响。
Am J Cardiol. 2006 Jun 15;97(12):1769-75. doi: 10.1016/j.amjcard.2006.01.040. Epub 2006 May 3.
9
Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy. Acute Doppler echocardiographic and catheterization hemodynamic study.双腔起搏对肥厚型心肌病患者收缩和舒张功能的影响。急性多普勒超声心动图和心导管血流动力学研究。
J Am Coll Cardiol. 1996 Feb;27(2):421-30. doi: 10.1016/0735-1097(95)00445-9.
本文引用的文献
1
ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines).美国心脏病学会/美国心脏协会/北美心脏起搏与电生理学会2002年心脏起搏器与抗心律失常器械植入指南更新：总结篇：美国心脏病学会/美国心脏协会实践指南工作组（美国心脏病学会/美国心脏协会/北美心脏起搏与电生理学会1998年起搏器指南更新委员会）报告
Circulation. 2002 Oct 15;106(16):2145-61. doi: 10.1161/01.cir.0000035996.46455.09.
2
Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death.肥厚型心肌病：管理、风险分层及猝死预防
Heart. 2002 Feb;87(2):169-76. doi: 10.1136/heart.87.2.169.
3
Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy.维拉帕米对肥厚型心肌病患者左心室收缩功能和舒张充盈的影响。
Circulation. 1981 Oct;64(4):787-96. doi: 10.1161/01.cir.64.4.787.
4
Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features.肥厚型心肌病的预后：年龄及临床、心电图和血流动力学特征的作用
Am J Cardiol. 1981 Mar;47(3):532-8. doi: 10.1016/0002-9149(81)90535-x.
5
Current operative treatment of obstructive hypertrophic cardiomyopathy.
Circulation. 1988 Sep;78(3):487-95. doi: 10.1161/01.cir.78.3.487.
6
Functional assessment of patients treated with permanent dual chamber pacing as a primary treatment for hypertrophic cardiomyopathy.对采用永久性双腔起搏作为肥厚型心肌病主要治疗方法的患者进行功能评估。
Eur Heart J. 1988 Aug;9(8):893-8. doi: 10.1093/oxfordjournals.eurheartj.a062584.
7
Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy.双腔永久起搏对维拉帕米和β-肾上腺素能阻滞剂治疗无效的梗阻性肥厚型心肌病患者的影响。
Circulation. 1992 Jun;85(6):2149-61. doi: 10.1161/01.cir.85.6.2149.
8
Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy.双腔起搏对肥厚性梗阻性心肌病的影响。
Lancet. 1992 May 30;339(8805):1318-23. doi: 10.1016/0140-6736(92)91961-7.
9
Mitral valve replacement for idiopathic hypertrophic subaortic stenosis. Results in 27 patients.二尖瓣置换术治疗特发性肥厚性主动脉瓣下狭窄。27例患者的结果。
J Cardiovasc Surg (Torino). 1976 Sep-Oct;17(5):380-7.
10
Long-term medical management of hypertrophic obstructive cardiomyopathy.肥厚性梗阻性心肌病的长期药物治疗
Am J Cardiol. 1978 Dec;42(6):993-1001. doi: 10.1016/0002-9149(78)90687-2.
Zotero 插件